Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma	classic Hodgkin lymphoma	Recruiting	Phase 2	2024-08-23		NCT04838652

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Cologne	43

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
1st Department of Medicine, Cologne University Hospital	Cologne	Germany	4

Clinical trials